New Cancer Drug Shows 78% Response in Colorectal Patients

A groundbreaking cancer treatment achieved a 78% response rate in colorectal cancer patients who had already failed other therapies.

The experimental drug also helped 85% of patients survive two years, compared to just 40% with standard treatment.